Eom HS - Search Results

1

T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction.

Eom HS, Rubio MT, Means TK, Luster AD, Sykes M. Eom HS, et al. Exp Hematol. 2005 Dec;33(12):1564-73. doi: 10.1016/j.exphem.2005.08.003. Exp Hematol. 2005. PMID: 16338500 Free article.

2

Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions.

Chakraverty R, Eom HS, Sachs J, Buchli J, Cotter P, Hsu R, Zhao G, Sykes M. Chakraverty R, et al. Among authors: eom hs. Blood. 2006 Sep 15;108(6):2106-13. doi: 10.1182/blood-2006-03-007427. Epub 2006 Jun 6. Blood. 2006. PMID: 16757687 Free PMC article.

3

The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells.

Chakraverty R, Flutter B, Fallah-Arani F, Eom HS, Means T, Andreola G, Schwarte S, Buchli J, Cotter P, Zhao G, Sykes M. Chakraverty R, et al. Among authors: eom hs. J Immunol. 2008 Nov 15;181(10):6820-8. doi: 10.4049/jimmunol.181.10.6820. J Immunol. 2008. PMID: 18981100

4

Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models.

Shin JH, Park HB, Oh YM, Lim DP, Lee JE, Seo HH, Lee SJ, Eom HS, Kim IH, Lee SH, Choi K. Shin JH, et al. Among authors: eom hs. Blood. 2012 Jun 14;119(24):5678-87. doi: 10.1182/blood-2011-09-380519. Epub 2012 Apr 26. Blood. 2012. PMID: 22538857 Free article.

5

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.

Kim DY, Joo YD, Lim SN, Kim SD, Lee JH, Lee JH, Kim DH, Kim K, Jung CW, Kim I, Yoon SS, Park S, Ahn JS, Yang DH, Lee JJ, Lee HS, Kim YS, Mun YC, Kim H, Park JH, Moon JH, Sohn SK, Lee SM, Lee WS, Kim KH, Won JH, Hyun MS, Park J, Lee JH, Shin HJ, Chung JS, Lee H, Eom HS, Lee GW, Cho YU, Jang S, Park CJ, Chi HS, Lee KH; Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology. Kim DY, et al. Among authors: eom hs. Blood. 2015 Aug 6;126(6):746-56. doi: 10.1182/blood-2015-03-636548. Epub 2015 Jun 11. Blood. 2015. PMID: 26065651 Free article. Clinical Trial.

6

Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

Kim SY, Lee H, Han MS, Shim H, Eom HS, Park B, Kong SY. Kim SY, et al. Among authors: eom hs. Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):527-535.e2. doi: 10.1016/j.clml.2016.06.013. Epub 2016 Jun 8. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27375156

7

Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors.

Eom HS, Choi BK, Lee Y, Lee H, Yun T, Kim YH, Lee JJ, Kwon BS. Eom HS, et al. J Immunother. 2016 Apr;39(3):140-8. doi: 10.1097/CJI.0000000000000113. J Immunother. 2016. PMID: 26938947 Free PMC article. Clinical Trial.

8

CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy.

Park HB, Lee JE, Oh YM, Lee SJ, Eom HS, Choi K. Park HB, et al. Among authors: eom hs. Exp Mol Med. 2017 Jul 28;49(7):e360. doi: 10.1038/emm.2017.104. Exp Mol Med. 2017. PMID: 28751785 Free PMC article.

9

Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Lim SN, Joo YD, Lee KH, Kim DY, Lee JH, Lee JH, Chi HS, Yun SC, Lee WS, Lee SM, Park S, Kim I, Sohn SK, Moon JH, Ryoo HM, Bae SH, Hyun MS, Kim MK, Kim HJ, Yang DH, Eom HS, Lee GW, Jung CW, Won JH, Kim H, Lee JH, Shin HJ, Jang DY. Lim SN, et al. Among authors: eom hs. Am J Hematol. 2015 Nov;90(11):1013-20. doi: 10.1002/ajh.24137. Epub 2015 Oct 12. Am J Hematol. 2015. PMID: 26228525 Free article. Clinical Trial.

10

Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.

Kim SJ, Kim K, Kim BS, Jo DY, Kang HJ, Kim JS, Mun YC, Kim CS, Sohn SK, Eom HS, Kwak JY, Shim H, Yoon HJ, Jin JY, Min CK, Shin H, Won JH, Lee JJ, Kwon JH, Joo YD, Do YR, Kim SH, Oh S, Suh C, Lee J, Yoon SS, Kim MK, Bang SM, Ryoo HM, Kim BS, Kim H, Kim HJ, Kim YS, Park CW, Lee GW, Shin HJ, Park SK, Park JS, Kim HY, Lee DS, Lee JH; Korean Multiple Myeloma Working Party. Kim SJ, et al. Among authors: eom hs. Acta Haematol. 2009;122(4):200-10. doi: 10.1159/000253027. Epub 2009 Oct 29. Acta Haematol. 2009. PMID: 19887776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters